Track the 제노레이 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 제노레이 has published 38 reports. Market capitalisation: €42bn. The latest transaction was reported on 27 May 2026 (Other). Among the most active insiders: 박병욱. The full history is accessible without an account.
38
Insider Decl.
0
Thresholds
€10,111
21 ops.
Buy Volume
€45,054
2 ops.
Sell Volume
22Σ signal
Buys €10,111€45,054 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 14,711 of 26,212 companies
48.4
score / 100
Value
62
Quality
35
FCF yld9.1%
Earn yld1.8%
EV/EBITDA9.0x
ROE0.1%
Gross mgn39%
Net mgn0.7%
Debt/EBITDA4.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.